Navigating FTC and state rules for hospital advertising claims

A billboard on Interstate 95 reads: "The #1 Heart Center in the Region." No source, no category, no date. Four parties can act on that one line, on four different theories: the FTC for deception, a state attorney general under its own consumer-protection statute, a competitor under the Lanham Act, and Google, which can decline to run the digital version and leave you no appeal worth the name.

Those four gates decide what a hospital may say at all. The evidence file behind a survival claim, who a campaign quietly leaves out, and who signs the release form belong to the later lessons in this module.

Who regulates hospital advertising

The FTC polices "unfair or deceptive acts or practices" under Section 5 of the FTC Act. Hospitals are commercial advertisers like any retailer. There is no pre-clearance: the agency acts after publication.

Deception has three elements, set out in the FTC's 1983 policy statement: a representation or omission likely to mislead a consumer acting reasonably, and material to that consumer's decision. Three consequences follow that marketing teams underrate.

• The agency reads the net impression of the whole ad, not sentences one at a time. Every word can be literally true and the ad still deceptive.
• Implied claims count as much as express ones. "Advanced robotic surgery, faster recovery" implies a comparison you now have to prove.
• Where an ad is aimed at a defined group, reasonableness is judged from that group's point of view. An oncology ad is read the way an anxious patient reads it, not the way counsel reads it.

Unfairness is the other prong, and hospitals forget it exists. Under 15 U.S.C. 45(n), a practice is unfair if it causes substantial injury consumers cannot reasonably avoid, and the injury is not outweighed by benefits to consumers or competition. Truthfulness is no defense. A "free" community heart screening that routes attendees into billable follow-up they never agreed to, or an online sign-up flow that hides how to cancel, raises an unfairness question even when every sentence in the creative is accurate.

State consumer-protection statutes, the UDAP laws, give attorneys general and often private plaintiffs the power to sue over the same claims. California's Unfair Competition Law and New York General Business Law Section 349 are the most heavily used. That state layer got heavier after AMG Capital Management v. FTC (2021), where the Supreme Court held unanimously that Section 13(b) does not authorise monetary relief. The Commission can still order you to stop and to substantiate; the money now arrives through state actions, rule violations, or class plaintiffs.

The FTC's own Advertising FAQ's: A Guide for Small Business is the plain-language federal primer, and its Health Products Compliance Guidance (2022) is the health-claim companion. Licensing boards and, for drug and device claims, the FDA sit on top. Patient data and outboundoutboundProactive outreach that pushes your message to targeted audiences through advertising, email, or direct prospecting, initiated by the seller rather than the buyer.View full definition → messaging run on a separate track: the HIPAA and TCPA constraints the compliant-marketing lesson sets out. A claim can be flawless under Section 5 and still unlawful there.

The claim types that draw scrutiny

Outcome, ranking and superiority claims carry the exposure. Each needs substantiation in hand before publication, and for health outcomes that means competent and reliable scientific evidence.

POM Wonderful shows what that phrase costs. The company had funded years of pomegranate research, reportedly tens of millions of dollars of it, then advertised that its juice treats or prevents heart disease, prostate cancer and erectile dysfunction. The FTC found the claims unsupported, and in 2015 the D.C. Circuit upheld the order while trimming the remedy: at least one randomised controlled trial is required for a disease claim, rather than the two the Commission had demanded. Money spent on research is not substantiation. The fit between the study design and the sentence in the ad is.

Rankings are lawful when truthful and sourced. They fail on scope and staleness: recognition in one narrow service line advertised as "the region's #1 hospital," or a 2019 award still running in 2026 with no year attached. Deception by omission needs no false word.

Superiority claims carry the heaviest burden, because they require head-to-head evidence measuring the same thing the same way. "Most advanced cardiac care in the region" is treated as an objective claim if a consumer reads it as fact, and it is close to unprovable. How you build the proof file behind an outcome or ranking claim is the next lesson's subject.

Platform certification gates

Before any of this reaches a regulator, it has to clear the ad platforms, and their rules bite earlier and harder. Google Ads and Meta both require US addiction-treatment advertisers to hold LegitScript certification, with separate certification tracks for telehealth and pharmacy categories. LegitScript sells the certification it audits against. It charges an annual fee, runs a document review that takes weeks, and inspects things no statute reaches: ownership structure, patient-brokering arrangements, call-centre scripts, insurance-verification language. Google then layers its own certification on top of the LegitScript one.

Three practical effects:

1. A legally clean campaign can be undeliverable for a quarter because certification is pending. Budget calendars built on a launch date, not a certification date, slip.
2. The platform's remedy is account suspension, decided without a hearing and on its own timetable.
3. Certification is held at the entity level, so losing it takes down the paid funnelfunnelThe customer journey from awareness to purchase, typically Awareness, Interest, Consideration, Decision, Action, with prospects narrowing at each stage.View full definition → for the whole service line, not just the ad that caused the problem.

Behavioural health, weight loss and fertility lines should be checked for the gate at the brief stage, not after the creative is shot.

Back to the billboard

"#1 Heart Center in the Region" fails on every gate at once:

• Ranking: no awarding body, no category, no geography that means anything, no year.
• Superiority: a naked superlative against every competitor in an undefined region.
• Net impression: "#1" tells a patient the clinical results are better, without naming a measure.

A small-print asterisk does not repair it. Disclosures must be clear and conspicuous: near the claim, legible in the actual medium, and not contradicted by the headline. Nothing is conspicuous on a billboard at 70 mph, which is the point worth taking away. In media that cannot carry a qualifier, you do not add a footnote. You change the claim.

Testimonials and reviews

Patient testimonials are advertising. The FTC's Endorsement Guides, updated in 2023, govern them.

Lumosity is the useful case, and not only for the science. The FTC's 2016 order cost the brain-training company $2 million in refunds for claims that its games reduced cognitive decline and staved off dementia. The complaint also charged that Lumosity had solicited consumer testimonials through a contest offering prizes, including trips and iPads and lifetime subscriptions, without disclosing that. Two rules transfer directly to a hospital: a patient story obtained through a raffle, a gift card or a waived co-pay is a paid endorsement, and a story about an unusual result carries an implied claim that the result is typical.

• Any material connection between the hospital and the endorser must be disclosed: employment, payment, free or discounted treatment, a foundation grant.
• An atypical outcome needs either substantiation that it is representative, or a disclosure that it is not. "Results vary" in grey 8-point type is not that disclosure.
• Fake reviews, review suppression and undisclosed insider reviews are prohibited under the FTC's 2024 consumer-review rule. Rule violations carry civil penalties north of $50,000 per violation, adjusted annually, which is exactly the exposure AMG left intact.

The state overlay

State attorneys general concentrate on two hospital-specific claim families.

Price and coverage promises. "We accept all insurance," "affordable care," "no out-of-network surprises." These are factual statements, and an AG will read them against your contracted payer list and your actual billing behaviour.

Charity care and community benefit. Advertising financial assistance while collections practice contradicts it is the fastest route to a state investigation, because the ad becomes evidence about the conduct. Nonprofit status invites the question rather than answering it.

Targeting decisions carry their own fairness exposure, which the non-discrimination lesson takes up.

Classifying a claim before it goes out

The classification work happens at the copy line, long before the formal review the closing lesson describes.

Inventory. Split every factual or implied statement out separately. "#1 heart center" is three claims: ranking, superiority, and an implied outcome.

Classify. Puffery is subjective opinion no reasonable person reads as fact ("compassionate care," "a warm environment") and is generally safe. Anything measurable needs proof.

Source and date. Rankings carry the awarding body, category, geography and year inside the ad.

Test the medium. A disclosure that works on a landing pagelanding pageA standalone web page built for a single campaign goal, designed to maximise conversions by removing distractions and focusing visitors on one action.View full definition → may be impossible in a 15-second radio spot.

Worked example

Proposed tagline: "The region's best heart center, with survival rates 20% above average."

Fix: "Cardiac surgery survival rates 20% higher than the national average, based on risk-adjusted 2025 CMS data." Drop "best." Define the comparator. Name the source and year.

Key takeaways

• Section 5 has two prongs. Deception turns on the net impressionimpressionThe total number of times an ad or piece of content is displayed, regardless of clicks. Each display counts as one impression, even to the same person.View full definition → on a reasonable consumer; unfairness can catch a campaign in which every sentence is true.
• AMG (2021) moved the money. Federal orders stop conduct; state AGs, FTC rules and private plaintiffs collect.
• Substantiation is about fit, not spend. POM Wonderful funded the research and still lost, because disease claims need at least one controlled trial that tests the claim actually made.
• Platform certification is the earliest gate. LegitScript and Google can suspend a whole service line's paid funnel on their own timetable, with no hearing.
• Testimonials obtained through contests, gift cards or waived charges are paid endorsements, and review manipulation now carries per-violation penalties.

This lesson is educational and not legal advice. Route specific campaigns to qualified counsel.